Status:
TERMINATED
Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)
Lead Sponsor:
FibroGen
Conditions:
Focal Segmental Glomerulosclerosis
Eligibility:
All Genders
12-64 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the safety and tolerability of FG-3019 administered over 8 weeks to adolescent and adult subjects with steroid-resistant focal segmental glomerulosclerosis (FS...
Eligibility Criteria
Inclusion
- Age 12-64 years, inclusive, and girls age 10-11 years, inclusive if Tanner stage 3 or greater
- Biopsy diagnosis of primary FSGS with biopsy confirmed centrally
- Age less than or equal to 2 years old at onset of proteinuria
- First morning urine protein/creatinine ratio (U p/c) \>1 gm/gm
- Estimated glomerular filtration rate greater than or equal to 40 mL/min/1.73 m2
Exclusion
- Non-FSGS renal disease other than benign cyst; or secondary FSGS
- History of organ transplantation
- History of allergic or anaphylactic reaction to human, humanized, chimeric or murine monoclonal antibodies
- History of malignancy, cardiovascular disease, diabetes mellitus, sickle cell disease, multiple sclerosis, systemic lupus erythematosus, or active or recurrent serious infections (including but not limited to Hepatitis B, Hepatitis C, or HIV)
- Participation in studies of investigational drugs within 6 weeks prior to Day 0 or receipt of an investigational drug within 12 weeks prior to Day 0
- Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \> 2.5 times the upper limit of normal
- Hematocrit \< 30%
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 18 2009
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00782561
Start Date
April 1 2008
End Date
June 18 2009
Last Update
July 31 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
New Hyde Park, New York, United States, 11040
2
Chapel Hill, North Carolina, United States, 27599-7155
3
Columbus, Ohio, United States, 43205